What is TULSA
The main objective of the TULSA treatment is to kill diseased prostate tissue while protecting the surrounding organs and structures, better maintaining the functions of those organs and structures when it comes to potency and continence.
What does TULSA stand for?
TULSA stands for Transurethral Ultrasound Ablation of the Prostate. The therapy treatment is performed in combination with real-time MR Imaging, thermal Ultrasound and a closed-loop temperature feedback control. As such it is performed in an MRI examination room and not in an operating theatre.
The Steps of Treatment
Potential Benefits and Advantages
How long does the treatment take?
The treatment is performed in a single session that takes a few hours. It is usually conducted under general anesthesia. After the treatment, the doctor may decide to keep the patient in the hospital overnight for observation or the patient may go home the same day.
Do I qualify for a TULSA?
The TULSA procedure has been developed for patients with localised tumours (cancer restricted/limited to the prostate). Patients with low to intermediate risk prostate cancer may benefit from the TULSA procedure. Topline results of the performed clinical trial for patients with Gleason scores 6 and 7 has been announced on April 4, 2019.⁶
Whether or not you will qualify for a TULSA will be decided by the treating Physician.
First TULSA Treatment at LHSC and 2nd treated Patient
“Everything has returned to normal and in some cases is better that what it has been for five years.” ⁷
Joseph Chin MD, FRCSC and his first TULSA patient Brian (Treatment in London, ON, Canada - 2013)
⁵ Laurence Klotz et al. (2018): LBA20 MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) IN PATIENTS WITH LOCALIZED PROSTATE CANCER: PRELIMINARY RESULTS OF TACT PIVOTAL STUDY, In: The Journal of Urology, 199(4):e1077-e1078.
⁶ https://www.globenewswire.com/news-release/2019/04/04/1797449/0/en/Profound-Medical-Announces-Positive-Topline-Results-from-TACT-Pivotal-Clinical-Trial-of-TULSA-PRO-in-Patients-with-Prostate-Cancer.html, May 2019.